agilon health inc. (NYSE:AGL) shares, rose in value on Wednesday, 08/24/22, with the stock price up by 2.99% to the previous day’s close as strong demand from buyers drove the stock to $22.05.
Actively observing the price movement in the last trading, the stock closed the session at $21.41, falling within a range of $20.18 and $22.405. Referring to stock’s 52-week performance, its high was $38.47, and the low was $14.36. On the whole, AGL has fluctuated by -15.03% over the past month.
3 Tiny Stocks Primed to Explode
The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
With the market capitalization of agilon health inc. currently standing at about $9.23 billion, investors are eagerly awaiting this quarter’s results, scheduled for Oct 28, 2021. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.02, which is expected to increase to -$0.01 for fiscal year -$0.13 and then to about $0.08 by fiscal year 2023. Data indicates that the EPS growth is expected to be 88.10% in 2023, while the next year’s EPS growth is forecast to be 161.50%.
Analysts have estimated the company’s revenue for the quarter at $647.98 million, with a low estimate of $645 million and a high estimate of $652.2 million. According to the average forecast, sales growth in current quarter could jump up 29.90%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2023, the company’s y-o-y revenues would reach $2.58 billion, representing an increase of 40.70% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that AGL’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium term indicators have put the stock in the category of 50% Buy while long term indicators on average have been pointing out that it is a 75% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of AGL currently trading nearly -8.85% and -6.90% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.21, while the 7-day volatility ratio is showing 5.84% which for the 30-day chart, stands at 5.28%. Furthermore, agilon health inc. (AGL)’s average true range (ATR) is 1.39. The company’s stock has been forecasted to trade at an average price of $32.50 over the course of the next 52 weeks, with a low of $26.00 and a high of $41.00. Based on these price targets, the low is -17.91% off current price, whereas the price has to move -85.94% to reach the yearly target high. Additionally, analysts’ median price of $32.50 is likely to be welcomed by investors because it represents a decrease of -47.39% from the current levels.
Data on historical trading for agilon health inc. (NYSE:AGL) indicates that the trading volumes over the past 10 days have averaged 3.14 million and over the past 3 months, they’ve averaged 2.42 million. According to company’s latest data on outstanding shares, there are 407.34 million shares outstanding.
Nearly 1.10% of agilon health inc.’s shares belong to company insiders and institutional investors own 98.76% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 19.16 million shares as on Jul 14, 2022, resulting in a short ratio of 9.85. According to the data, the short interest in agilon health inc. (AGL) stood at 4.71% of shares outstanding as of Jul 14, 2022; the number of short shares registered in Jun 14, 2022 reached 20.03 million. The stock has fallen by -18.33% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AGL stock heading into the next quarter.